Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study
July 5, 2022 Kristjan Kaup, Madis Vasser, Kadi Tulver et al. 7 citations preprint
A 2-day virtual reality intervention called Psyrreal, designed to mimic the phenomenological components of psychedelic experiences, combined with psychological support, led to significant decreases in depressive symptoms at a 2-week follow-up in ten participants with mild-to-moderate depression. The intervention also appeared to promote insight and alterations in the sense of self in some people, based on thematic analysis of semi-structured interviews. These preliminary results suggest potential for VR experiences in treating depressive symptoms and warrant further research.